Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Rubra Medicaments
Add new alert
CHECKPOINT •
BSE
Checkpoint Trends
₹42.93
-2.25 (4.98%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
BSE •
5 days ago
Centuple Global Ltd schedules a Board Meeting on March 18, 2026 to address director changes. Trading window for insiders closes from March 10, 2026 until 48 hrs post-outcome announcement.
ScoutQuest •
1 week ago
Checkpoint Trends Ltd board okayed 1.66 cr convertible warrants at Rs. 45.01 each, worth Rs. 75.05 cr. 25% payment received upfront; balance within 18 months via private placement to promoters/non-promoters.
BSE •
3 weeks ago
Centuple Global Ltd schedules a board meeting on Feb 25, 2026 to discuss key changes including director resignations and appointments. Agenda includes company acquisition, approval of related party transactions, and trading window closure from Feb 20, 2026.
BSE •
2 months ago
Checkpoint Trends Ltd approved unaudited financial results for Q3 FY25. E-voting commences Jan 29, 2026; results to be published by Feb 3, 2026.
BSE •
2 months ago
Checkpoint Trends Ltd's Board to meet on Jan 28, 2026, to approve Q3 FY25 unaudited results. Trading window for insiders remains closed until 48 hours post results announcement.
BSE •
3 months ago
Checkpoint Trends Ltd schedules board meeting on Dec 3, 2025, to discuss key leadership changes. Agenda includes director resignations, re-designations, new appointments, and trading window closure till 48 hours post-outcome.
BSE •
4 months ago
Checkpoint Trends Ltd board meeting set for Nov 12, 2025 to review H1 FY26 financials. Trading window remains closed till 48 hrs post financial results announcement.
BSE •
5 months ago
Checkpoint Trends Ltd held its EGM on Oct 27, 2025 via VC/OAVM, chaired by Shubham Chaudhary. Key resolutions included convertible warrants issuance and capital raising via QIP, with voting conducted electronically.
ScoutQuest •
5 months ago
Checkpoint Trends Ltd plans capital raising via Preferential Issue (170L) and QIP (500L). Funds are for buyout, working capital, and corporate purposes; monitoring agency appointed.
BSE •
5 months ago
Checkpoint Trends Ltd issues corrigendum to EGM Notice, clarifying changes in the Explanatory Statement. Monitoring agency Acuite Ratings appointed for utilization of proceeds exceeding Rs.100 crore for Preferential Issue and QIP.